EUVIMEDEUVIMED entdecken
Crossref

Pooled CRISPR screens with joint single-nucleus chromatin accessibility and transcriptome profiling

Rachel E Yan, Alba Corman, Lyla Katgara, Xiao Wang, Xinhe Xue, Zoran Z Gajic, Richard Sam, Michael Farid, Samuel M Friedman, Jungwook Choo, Ivan Raimondi, Shridar Ganesan und 4 weitere

Nature Biotechnology · 2025-10 · 43 (10) · 1628-1634

DOI: 10.1038/s41587-024-02475-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nature Biotechnology, online erschienen am 21.11.2024. Verfasst von Rachel E Yan und 15 weiteren Autor:innen. Beteiligte Einrichtung: New York Genome Center, New York, NY, USA. Hauptthemen laut MEDLINE: Chromatin, Gene Expression Profiling, CRISPR-Cas Systems, Clustered Regularly Interspaced Short Palindromic Repeats. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI), U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS), U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pooled single-cell CRISPR screens have profiled either gene expression or chromatin accessibility but not both modalities. Here we develop MultiPerturb-seq, a high-throughput CRISPR screening platform with joint single-nucleus chromatin accessibility, transcriptome and guide RNA capture using combinatorial indexing combined with droplet microfluidics to scale throughput and integrate all three modalities. We identify key differentiation genes in a rare pediatric cancer and establish ZNHIT1 as a potential target for cancer reprogramming therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChromatinGene Expression ProfilingCRISPR-Cas SystemsClustered Regularly Interspaced Short Palindromic RepeatsCell NucleusHumansSingle-Cell AnalysisTranscriptome

Substanzen

Chromatin

Autor:innen und Institutionen

  • New York Genome Center, New York, NY, USA.
  • Department of Biology, New York University, New York, NY, USA.
  • Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Department of Neurological Surgery, Weill Cornell Medicine, New York, NY, USA.
  • Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Department of Statistics and Data Science, University of Pennsylvania, Philadelphia, PA, USA.

Förderung

  • U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI)
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
  • U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD)

Zitieren

APA

Yan, R. E., Corman, A., Katgara, L., Wang, X., Xue, X., Gajic, Z. Z., Sam, R., Farid, M., Friedman, S. M., Choo, J., Raimondi, I., Ganesan, S., Katsevich, E., Greenfield, J. P., Dahmane, N., & Sanjana, N. E. (2025). Pooled CRISPR screens with joint single-nucleus chromatin accessibility and transcriptome profiling. Nature Biotechnology, 43(10), 1628-1634. https://doi.org/10.1038/s41587-024-02475-x

Vancouver

Yan RE, Corman A, Katgara L, Wang X, Xue X, Gajic ZZ, et al. Pooled CRISPR screens with joint single-nucleus chromatin accessibility and transcriptome profiling. Nature Biotechnology. 2025;43(10):1628-1634. doi:10.1038/s41587-024-02475-x

BibTeX
@article{Yan2025,
  author = {Yan, Rachel E and Corman, Alba and Katgara, Lyla and Wang, Xiao and Xue, Xinhe and Gajic, Zoran Z and Sam, Richard and Farid, Michael and Friedman, Samuel M and Choo, Jungwook and Raimondi, Ivan and Ganesan, Shridar and Katsevich, Eugene and Greenfield, Jeffrey P and Dahmane, Nadia and Sanjana, Neville E},
  title = {Pooled CRISPR screens with joint single-nucleus chromatin accessibility and transcriptome profiling},
  journal = {Nature Biotechnology},
  year = {2025},
  volume = {43},
  number = {10},
  pages = {1628--1634},
  doi = {10.1038/s41587-024-02475-x}
}
Kostenlos starten →